MaxCyte MXCT Business Segments — Gross Profit
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by MaxCyte in its filing.
Tagged under the XBRL concept us-gaap:GrossProfit.
The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about MaxCyte's business segments — gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MaxCyte's business segments — gross profit?
- MaxCyte (MXCT) reported business segments — gross profit of $8.08M in Q1 2026.
- How has MaxCyte's business segments — gross profit changed year-over-year?
- MaxCyte's business segments — gross profit decreased by 9.1% year-over-year, from $8.89M to $8.08M.
- What is the long-term trend for MaxCyte's business segments — gross profit?
- Over 2 years (2023 to 2025), MaxCyte's business segments — gross profit has grown at a -14.4% compound annual growth rate (CAGR), from $36.55M to $26.8M.
- What does business segments — gross profit mean?
- Calculated as total segment revenue minus the direct costs of goods and services sold. It measures the fundamental profitability of the segment's products before accounting for operating expenses and overhead.